Amylyx Pharmaceuticals Inc's total assets for Q1 2025 were $219.68M, an increase of 13.45% from the previous quarter. AMLX total liabilities were $18.26M for the fiscal quarter, a -36.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.